myocardial stunning

Search with Google Search with Bing
Information
Disease name
myocardial stunning
Disease ID
DOID:9767
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT06450912 Completed Wall Strain Index Ratio as a Biomarker for Mechanical Complication of Hemorrhagic Myocardial Infarction June 1, 2022 June 1, 2024
NCT00213746 Completed Evaluation of Myocardial Viability by Means of Low-dose Dobutamine Gated SPECT (the DOGS Study) October 2003 December 2005
NCT01179802 Completed N/A Exercise-induced Changes in Cardiac Function & Morphology July 2010 October 2010
NCT02545426 Completed N/A Myocardial Stunning During Hemodialysis: Role of Dialyste Calcium Concentration July 2015 April 2016
NCT06308107 Not yet recruiting Phase 1 Safety and Feasibility of Hyperkalemic Cardioplegia With Diazoxide in Cardiac Surgery (CPG-DZX) Trial July 1, 2024 April 30, 2028
NCT05669144 Recruiting Phase 1/Phase 2 Co-transplantation of Mesenchymal Stem Cell Derived Exosomes and Autologous Mitochondria for Patients Candidate for CABG Surgery April 20, 2022 September 20, 2024
NCT05209230 Recruiting N/A Is Myocardial Stunning Induced by Continuous Renal Replacement Therapy a Reality in Critically Ill Patients? April 15, 2022 June 16, 2025
NCT04448639 Recruiting Stunning in Takotsubo Versus Acute Myocardial Infarction December 12, 2019 December 2030
NCT01500785 Terminated Phase 4 Intracoronary Administration of Levosimendan in Cardiac Surgery Patients June 15, 2018 September 11, 2019
NCT00123695 Unknown status Serial Echocardiography After Subarachnoid Hemorrhage May 2005 June 2008
NCT04830982 Withdrawn Phase 1 Safety and Efficacy of IV Diazoxide as an Additive to Hyperkalemic Cardioplegia in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass September 1, 2023 October 30, 2025
NCT02770183 Withdrawn Rate of Left Ventricular Systolic Function's Recuperation After Cardiac Surgery With Extracorporeal Circulation. December 1, 2019 December 2020
NCT02687269 Withdrawn Phase 4 Ranolazine a Potential New Therapeutic Application April 10, 2019 October 2020
Disase is a (Disease Ontology)
DOID:5844
Cross Reference ID (Disease Ontology)
MESH:D017682
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0206146
MedGen concept unique identifier (MedGen Concept name)
C0206146
MedGen unique identifier (MedGen Concept name)
61526
MeSH unique ID (MeSH (Medical Subject Headings))
D017682